K960257

Substantially Equivalent

N ANTISERUM TO C1 INHIBITOR

Applicant: Behring Diagnostics, Inc.
Product code: DBA
Advisory panel: Immunology
Date received: 1996-01-18
Decision date: 1996-08-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Westwood, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.